0001209191-22-002215.txt : 20220106
0001209191-22-002215.hdr.sgml : 20220106
20220106170042
ACCESSION NUMBER: 0001209191-22-002215
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220104
FILED AS OF DATE: 20220106
DATE AS OF CHANGE: 20220106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schambye Hans T.
CENTRAL INDEX KEY: 0001825776
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39655
FILM NUMBER: 22515483
MAIL ADDRESS:
STREET 1: C/O GALECTO, INC.
STREET 2: OLE MAALOES VEJ 3
CITY: COPENHAGEN N
STATE: G7
ZIP: DK-2200
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Galecto, Inc.
CENTRAL INDEX KEY: 0001800315
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 371957007
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 STATE STREET
STREET 2: SUITE 100
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 45-70-70-52-10
MAIL ADDRESS:
STREET 1: 75 STATE STREET
STREET 2: SUITE 100
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: Galecto Inc.
DATE OF NAME CHANGE: 20200116
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-04
0
0001800315
Galecto, Inc.
GLTO
0001825776
Schambye Hans T.
C/O GALECTO, INC.
OLE MAALOES VEJ 3
COPENHAGEN N
G7
DK-2200
DENMARK
1
1
0
0
Chief Executive Officer
Stock Option (right to buy)
3.24
2022-01-04
4
A
0
287500
0.00
A
2032-01-03
Common Stock
287500
287500
D
25% of the shares subject to such option vested and became exercisable on January 4, 2023 and the remainder of the shares vest in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
/s/ Lori Firmani, attorney-in-fact
2022-01-06